Albumin-bilirubin versus Child-Pugh score as a predictor of outcome after liver resection for hepatocellular carcinoma.
about
Controversies and evidence of hepatic resection for hepatocellular carcinomaRisk stratification system to predict recurrence of intrahepatic cholangiocarcinoma after hepatic resection.High expression of AKR1B10 predicts low risk of early tumor recurrence in patients with hepatitis B virus-related hepatocellular carcinoma.Albumin to gamma-glutamyltransferase ratio as a prognostic indicator in intrahepatic cholangiocarcinoma after curative resection.Combining albumin-bilirubin score with future liver remnant predicts post-hepatectomy liver failure in HBV-associated HCC patients.Prognostic value of the albumin-bilirubin grade in patients with hepatocellular carcinoma: Validation in a Chinese cohort.Albumin-Bilirubin Score: Predicting Short-Term Outcomes Including Bile Leak and Post-hepatectomy Liver Failure Following Hepatic Resection.Usefulness of albumin-bilirubin grade for evaluation of long-term prognosis for hepatitis B-related cirrhosis.Preoperative direct bilirubin to prothrombin time ratio index to prevent liver failure after minor hepatectomy.Clinical importance of TERT overexpression in hepatocellular carcinoma treated with curative surgical resection in HBV endemic area.RAM score is an effective predictor for early mortality and recurrence after hepatectomy for hepatocellular carcinoma.Liver Function Assessment Using Albumin-Bilirubin Grade for Patients with Very Early-Stage Hepatocellular Carcinoma Treated with Radiofrequency Ablation.Albumin-Bilirubin (ALBI) Grade as Part of the Evidence-Based Clinical Practice Guideline for HCC of the Japan Society of Hepatology: A Comparison with the Liver Damage and Child-Pugh Classifications.Albumin-Bilirubin Grade and Hepatocellular Carcinoma Treatment Algorithm.Predictors of Futile Liver Resection for Patients with Barcelona Clinic Liver Cancer Stage B/C Hepatocellular Carcinoma.Proposal of a New Preoperative Prognostic Model for Solitary Hepatocellular Carcinoma Incorporating 18F-FDG-PET Imaging with the ALBI Grade.Value of the albumin-bilirubin score in the evaluation of hepatitis B virus-related acute-on-chronic liver failure, liver cirrhosis, and hepatocellular carcinoma.Liver Resection and Surgical Strategies for Management of Primary Liver Cancer.Assessment of the Albumin-Bilirubin (ALBI) Grade as a Prognostic Indicator for Hepatocellular Carcinoma Patients Treated With Radioembolization.Preoperative platelet-albumin-bilirubin grades predict the prognosis of patients with hepatitis B virus-related hepatocellular carcinoma after liver resection: A retrospective study.Preoperative survival calculator for resectable hepatocellular carcinoma.Transarterial chemoembolization as a substitute to radiofrequency ablation for treating Barcelona Clinic Liver Cancer stage 0/A hepatocellular carcinoma.Update on Liver Failure Following Hepatic Resection: Strategies for Prediction and Avoidance of Post-operative Liver Insufficiency.Comparison of platelet-albumin-bilirubin (PALBI), albumin-bilirubin (ALBI), and child-pugh (CP) score for predicting of survival in advanced hcc patients receiving radiotherapy (RT).Postoperative survival analysis and prognostic nomogram model for patients with portal hypertensionIs there an optimal staging system or liver reserve model that can predict outcome in hepatocellular carcinoma?
P2860
Q28072742-F8099206-3F9B-4CF3-8DDE-EE1B513244C0Q33869560-00BE35F1-7814-4EA4-9240-B862AB15E950Q37633872-92A91797-8597-4744-991A-81C0B52D5F97Q37706596-E6BAC618-E2DD-41BC-BF91-EF18D3EB8DB6Q38661384-C7A762E0-3337-46BB-AE5D-C4AD547749C8Q38799370-A0A7DBD1-6FFC-4C03-AD00-D290CEF95D01Q40404238-519DC99D-5EF3-4FA3-8AB7-9C22B2C057B1Q40468451-B9B10350-B654-469E-995C-E61CBF1DB7B8Q40550133-56AB2CE7-7F9F-4312-92E1-EC81D085D56DQ42363722-3C3AE7F5-F63B-47B1-835C-509A8A1DA631Q47201893-56722DBB-FB56-4075-8813-AB9DFBAE7139Q47688758-C3B8CD34-ECAF-4408-928A-9C60B74B56F8Q47796906-EB5FC1CF-EB70-41B8-90CE-D178EDD244FEQ47796915-CFEC3BBB-9B1C-4DB4-9562-AEF3155BE4A0Q48337055-30BB63E9-AB01-4F4F-87CD-160FAF9D0054Q49720916-23841238-35B2-48F5-B14A-D26BD3E13894Q49875117-1605A8B0-F2EB-4A50-9905-8105C33C3BC6Q50072154-EBEABFC3-50A2-4360-8998-5A63CB409E77Q53840262-70B1A29E-7ABA-4B8C-9C45-C3BEC1A37969Q54251873-92360ECD-F850-4915-BFD1-0C4703BEC113Q55082575-FFB38ADD-5087-45AF-8E46-68B6C3CF0C2DQ55256355-4CCBB144-E2A6-4ECE-B1D8-5FC0C68FEAA7Q55257627-9A2A76F0-D0F0-459B-B03D-5C33D1E35722Q55508855-DDA5BE3D-2214-4C3C-B49E-4C4F1EAC9D7AQ57807158-4B2CBCBC-30FF-459B-B1D7-C01AB69210DFQ58806088-DFDFCEF4-8365-4A84-84AD-2B2D20D35F28
P2860
Albumin-bilirubin versus Child-Pugh score as a predictor of outcome after liver resection for hepatocellular carcinoma.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Albumin-bilirubin versus Child ...... for hepatocellular carcinoma.
@en
type
label
Albumin-bilirubin versus Child ...... for hepatocellular carcinoma.
@en
prefLabel
Albumin-bilirubin versus Child ...... for hepatocellular carcinoma.
@en
P2093
P2860
P356
P1476
Albumin-bilirubin versus Child ...... for hepatocellular carcinoma.
@en
P2093
P2860
P304
P356
10.1002/BJS.10095
P407
P577
2016-03-23T00:00:00Z